(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 65.31%-21.55K | 164.40%45.68K | 21.32%-209.73K | 23.73%-60.81K | 44.11%-15.89K | 23.16%-62.11K | 8.59%-70.93K | 62.07%-266.57K | 43.32%-79.72K | 82.77%-28.43K |
Net income from continuing operations | 159.43%139.75K | 1,025.58%180.21K | -5,261.30%-23.15M | -15,170.38%-22.86M | 24.42%-35.41K | -89.12%-235.13K | 82.45%-19.47K | 55.91%-431.81K | -24.20%-149.7K | 76.95%-46.84K |
Operating gains losses | ---168.42K | ---148.11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -31.27%2.56K | -31.26%2.56K | -16.67%14.91K | -16.66%3.73K | -16.66%3.73K | -16.70%3.73K | -16.66%3.73K | -17.56%17.89K | -17.57%4.47K | -17.57%4.47K |
Asset impairment expenditure | ---- | ---- | --22.78M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Remuneration paid in stock | -93.30%10.68K | ---- | 189.35%210.36K | 25.81%19.12K | --31.82K | 525.14%159.41K | ---- | -73.62%72.7K | --15.2K | --0 |
Change In working capital | -161.89%-6.12K | 119.96%11.02K | -190.16%-67.3K | -111.85%-5.96K | -215.05%-16.04K | -26.98%9.88K | -1,659.29%-55.19K | 460.93%74.65K | 297.04%50.31K | 161.01%13.94K |
-Change in receivables | -47.99%9.73K | 1,086.30%14.46K | -150.77%-15.63K | -474.62%-19.98K | -26.00%-15.57K | -44.92%18.71K | -68.32%1.22K | -40.50%30.79K | 124.17%5.33K | -208.54%-12.36K |
-Change in payables and accrued expense | -79.60%-15.85K | 93.89%-3.45K | -217.80%-51.67K | -68.82%14.02K | -101.76%-463 | 56.81%-8.82K | -707.56%-56.41K | 160.57%43.86K | 1,398.79%44.98K | 176.82%26.3K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 65.31%-21.55K | 164.40%45.68K | 21.32%-209.73K | 23.73%-60.81K | 44.11%-15.89K | 23.16%-62.11K | 8.59%-70.93K | 62.07%-266.57K | 43.32%-79.72K | 82.77%-28.43K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 1,117.66%168.42K | 22,438.76%148.11K | 121.79%142.88K | -56.92%12.39K | 145.42%117.33K | 105.48%13.83K | 99.62%-663 | 59.16%-655.7K | 123.48%28.76K | -14.76%-258.3K |
Net PPE purchase and sale | 1,117.66%168.42K | --148.11K | --142.88K | --12.39K | --117.33K | --13.83K | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | 99.62%-663 | 59.16%-655.7K | 123.48%28.76K | -14.76%-258.3K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 1,117.66%168.42K | 22,438.76%148.11K | 121.79%142.88K | -56.92%12.39K | 145.42%117.33K | 105.48%13.83K | 99.62%-663 | 59.16%-655.7K | 123.48%28.76K | -14.76%-258.3K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Cash from discontinued financing activities | ||||||||||
Net cash flow | ||||||||||
Beginning cash position | 17.68%1.32M | -5.60%1.13M | -43.57%1.19M | -5.57%1.18M | -29.87%1.07M | -39.81%1.12M | -43.57%1.19M | -52.17%2.12M | -47.67%1.25M | -44.69%1.53M |
Current changes in cash | 404.24%146.87K | 370.67%193.79K | 92.75%-66.85K | 5.00%-48.42K | 135.38%101.44K | 85.51%-48.27K | 71.53%-71.6K | 60.05%-922.27K | 80.63%-50.97K | 26.49%-286.73K |
End cash Position | 36.64%1.47M | 17.68%1.32M | -5.60%1.13M | -5.60%1.13M | -5.57%1.18M | -29.87%1.07M | -39.81%1.12M | -43.57%1.19M | -43.57%1.19M | -47.67%1.25M |
Free cash from | 65.31%-21.55K | 164.40%45.68K | 21.32%-209.73K | 23.73%-60.81K | 44.11%-15.89K | 23.16%-62.11K | 8.59%-70.93K | 62.07%-266.57K | 43.32%-79.72K | 82.77%-28.43K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data